- Home
- OBIO vs MPV Comparison
OBIO vs MPV Comparison
Compare OBIO & MPV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OBIO | MPV |
|---|---|---|
| Founded | 2017 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 237.2M | 201.1M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | OBIO | MPV |
|---|---|---|
| Price | $4.37 | $18.99 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $14.25 | N/A |
| AVG Volume (30 Days) | ★ 206.0K | 10.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.71% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.71 |
| Revenue | ★ $2,638,000.00 | N/A |
| Revenue This Year | $36.66 | N/A |
| Revenue Next Year | $2.30 | N/A |
| P/E Ratio | ★ N/A | $11.13 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.20 | $15.16 |
| 52 Week High | $5.42 | $21.00 |
Technical Indicators
Market Signals| Indicator | OBIO | MPV |
|---|---|---|
| Relative Strength Index (RSI) | 59.30 | 45.70 |
| Support Level | $4.00 | $18.64 |
| Resistance Level | $5.00 | $19.46 |
| Average True Range (ATR) | 0.26 | 0.27 |
| MACD | 0.07 | -0.04 |
| Stochastic Oscillator | 90.00 | 23.80 |
Price Performance
Historical ComparisonAbout OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About MPV Barings Participation Investors
Barings Participation Investors is a diversified closed-ended management investment company. The Trust's investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. Its principal investments are privately placed, below-investment grade, long-term debt obligations including bank loans and mezzanine debt instruments. The company invests in various sectors such as aerospace and defense; automotive; building materials; consumer products and others.